Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
TreeFrog Therapeutics will participate for the first time at IAPRD to present data from its cellular therapy program for Parkinsons disease which has demonstrated excellent results with complete motor recovery
GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA GCA treatment has received FDA IND approval With this approval development of GCA is expected to accelerate
Protein Dynamic Solutions this week launched its StateoftheArt ProteinMentor platform technology at the PEGS Boston Summit ProteinMentor consists of a Quantum Cascade Laser
Virios Therapeutics Inc a developmentstage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases including fibromyalgia and LongCOVID
Glenmark Pharmaceuticals Ltd has received final approval by the United States Food Drug Administration for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution Glenmarks Brimonidine Tartrate
Axonics Inc today announced that it has received regulatory approval from the Therapeutic Goods Administration for marketing the Axonics F rechargefree sacral neuromodulation system in Australia to treat adults with overactive bladder Approval of the...
Oragenics Inc a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders today announced an update on the company and its drug development program
An exclusive Advance DoE Workshop hosted by Eminence Business Media concluded with resounding success inspiring participants with valuable insights to enhance their experimental design
Nitrosamine Advance Workshop conducted on May th and th at Radisson Blu Mumbai International Airport has emerged as a watershed moment in the pharma industry boosting collaboration and innovation in the detection of the Nitrosamine landscape
Scorpius Holdings Inc an integrated contract development and manufacturing organization today announced the successful validation of its microbial facilities
